The development of novel enzyme inhibitors has led to effective therapeutic options for diseases that were once considered difficult to treat. A newly updated study by BCC Research finds that approvals of new molecular entities will drive the global market for enzyme inhibitors to $179.9 billion by 2022. Enzyme inhibitors offer therapeutic options for myriad illnesses, including HCV, HIV, cancer, gastrointestinal disease, cardiovascular disease, inflammatory disorders, rheumatoid arthritis, neurological disorders (depression, Parkinson’s disease, Alzheimer’s disease) and diabetes.
There has been increasing interest in botanical drugs, with many players investigating their commercial potential. According to BCC Research, the global market for plant-derived and botanical drugs is expected to reach $39.6 billion by 2022. Excluding botanicals, growth in the plant-derived drug market is in line with the overall pharmaceutical industry, given the presence of generics (including biosimilars). Patent expirations will necessitate medicinal compounds other than single chemical entities. Growth in the U.S. market for plant-derived drugs will reflect new cannabinoids and their overall expanded uses, as well as eventual brand line extensions.
Ahead of the January 2018 update on the report “3D Cell Cultures: Technologies and Global Markets,” we are resharing Laurie Sullivan’s blog from July. On January 24, 2018, the analyst Robert G. Hunter will present a Member Exclusive Webinar and Q&A session on this report. Purchase the report or become a Member to attend!
With commercial applications in many fields, the total amino acid market in the United States is projected to approach $2.5 billion by 2022. Amino acids have important roles in food for human consumption, animal feed, cosmetics, medicines, biotechnology and some industrial applications. In dollar terms, the most important current applications are in animal feed and human food. The threeprimary categories of commercial amino acids in the United States—animal feeds, flavorants and specialty uses—comprise a market in excess of $1.9 billion. Accounting for 18% of global consumption, the U.S. market is forecast to expand at a compound annual growth rate of 4.8% from 2017 to 2022, according to a new study by BCC Research.